Skip to main content

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

Publication ,  Journal Article
Gradishar, WJ; Anderson, BO; Balassanian, R; Blair, SL; Burstein, HJ; Cyr, A; Elias, AD; Farrar, WB; Forero, A; Giordano, SH; Goetz, M ...
Published in: J Natl Compr Canc Netw
December 2015

These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the most recent version of these guidelines, the NCCN Breast Cancer Panel included a new section on the principles of preoperative systemic therapy. In addition, based on new evidence, the panel updated systemic therapy recommendations for women with hormone receptor-positive breast cancer in the adjuvant and metastatic disease settings and for patients with HER2-positive metastatic breast cancer. This report summarizes these recent updates and discusses the rationale behind them.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

December 2015

Volume

13

Issue

12

Start / End Page

1475 / 1485

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., … Kumar, R. (2015). NCCN Guidelines Insights Breast Cancer, Version 1.2016. J Natl Compr Canc Netw, 13(12), 1475–1485. https://doi.org/10.6004/jnccn.2015.0176
Gradishar, William J., Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, et al. “NCCN Guidelines Insights Breast Cancer, Version 1.2016.J Natl Compr Canc Netw 13, no. 12 (December 2015): 1475–85. https://doi.org/10.6004/jnccn.2015.0176.
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. NCCN Guidelines Insights Breast Cancer, Version 1.2016. J Natl Compr Canc Netw. 2015 Dec;13(12):1475–85.
Gradishar, William J., et al. “NCCN Guidelines Insights Breast Cancer, Version 1.2016.J Natl Compr Canc Netw, vol. 13, no. 12, Dec. 2015, pp. 1475–85. Pubmed, doi:10.6004/jnccn.2015.0176.
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA, Kumar R. NCCN Guidelines Insights Breast Cancer, Version 1.2016. J Natl Compr Canc Netw. 2015 Dec;13(12):1475–1485.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

December 2015

Volume

13

Issue

12

Start / End Page

1475 / 1485

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • Humans
  • Female
  • Breast Neoplasms
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis